press releases regarding Pharmaceuticals

Bilcare bags the coveted 2009 European Outsourcing award second time in succession

Bilcare Ltd., service provider to the pharmaceutical companies spanning across their value chain from drug discovery to market bags the prestigious 20

Bilcare, Marketing, News Today, Pharmaceuticals

No Comments

Bharat Biotech’s Rabies Vaccine ‘INDIRAB®’ Sales Crosses 10 Million Doses; Sales Expected to Double in Coming Years as Demand Increases in Developing World

Indian deaths from rabies account for nearly 35 percent of such deaths worldwide, according to data available with WHO. Worldwide nearly 55,000 people

Bharat Biotech, Marketing, News Today, Pharmaceuticals

No Comments

Granules Posts Record Revenue, Net Profit Increases 121%

- Revenue of 96.44 Cr Highest revenue achieved in a quarter by the company - Net profit of Rs 7.75 Cr - Consolidated turnover at Rs 114.55 Cr

Financial News, Granules India, News Today, Pharmaceuticals

No Comments

Wockhardt divests its Veterinary business to Vétoquinol

Pharmaceutical and biotechnology major Wockhardt Limited today announced the completion of the divestment of its Animal Health Division to Vétoquinol

Pharmaceuticals, Wockhardt

No Comments

Wockhardt’s Q2 Results 2009

Consolidated Sales at Rs. 954 crore Operating Profit (EBIDTA) at Rs. 168 crore Pharmaceutical and biotechnology major Wockhardt Limited today anno

Financial News, Pharmaceuticals, Wockhardt

No Comments

Wockhardt Signs Agreements to Divest its Nutrition Businesses to Abbott

Deal covers India’s leading paediatric and adult nutritional brands Farex and Protinex Pharmaceutical and biotechnology major Wockhardt Limited a

General News, Pharmaceuticals, Wockhardt

No Comments

Neuland Laboratories’ Q4 net profit increases by 152 per cent

•Records Impressive Performance in Q4 with net sales increase by 33 per cent for the quarter and 41 per cent for the fiscal April 2008- March 09

Financial News, Neuland Laboratories, Pharmaceuticals

No Comments

Ankur Drugs posts 43% hike in total income

Q4 Net Income up 16% at Rs.241.72 crore Ankur Drugs and Pharma Ltd., (BSE: 531683), one of the largest contract manufacturers of pharmaceutical for

Ankur Drugs and Pharma, Financial News, Pharmaceuticals

No Comments

Wockhardt announces Entacapone patent settlement with Orion Corporation

Pharmaceutical and biotechnology major Wockhardt Limited today announced that the Company and Wockhardt USA LLC, a subsidiary of the Company, have exe

Pharmaceuticals, Wockhardt

No Comments

TAKE Solutions adds Cadila Pharmaceuticals to their growing list of clients

Widens penetration amongst top Pharma companies Cadila Pharmaceuticals, one of India’s most reputed, Research based, Technology intensive pharmac

Cadila Pharmaceuticals, IT & ITES, Logistics, Pharmaceuticals, Products & Services

No Comments

Piramal Healthcare announces Q4 and FY 2009 results

Revenues for FY2009 up by 14.4% to Rs. 32.8 billion, EBITDA (excluding FOREX impact) for the year was up by 23.7% at Rs. 6.7 billion and Net Profit (e

Financial News, Healthcare, Pharmaceuticals, Piramal Group, Piramal Healthcare Ltd

No Comments

Troikaa Pharma Introduces Trofentyl OTFC

A New Drug for Breakthrough Cancer Pains Troikaa Pharmaceuticals Ltd has introduced Trofentyl OTFC, lozenge (tablet) for “breakthrough pains” i

Healthcare, Pharmaceuticals, Products & Services, Troikaa Pharmaceuticals

No Comments

Pushpinder Bindra Appointed Managing Director of Nektar Therapeutics (India) Private Limited

Nektar Therapeutics today announced the appointment of Pushpinder Bindra as Managing Director of Nektar Therapeutics (India) Private Limited, a wholly

HR, Management News, Nektar Therapeutics, Pharmaceuticals

No Comments

Piramal Healthcare reports Q3 FY2009 results; Consolidated revenues for the quarter up by 14.9% to Rs. 8.3 billion, Operating Profit (excluding FOREX impact) up by 40.6% to Rs.1.6 billion, Net Profit (before FOREX impact) up by 29.3% to Rs. 918.9 million

Piramal Healthcare Limited (Piramal Healthcare, earlier Nicholas Piramal India Limited) (NSE: PIRHEALTH, BSE: 500302) today reported third quarter (Q3

Financial News, Healthcare, Pharmaceuticals, Piramal Group, Piramal Healthcare Ltd

No Comments

Piramal Healthcare Limited to acquire Minrad International, Inc.

Piramal Healthcare Limited [NSE: Pirhealth, BSE: 500302], one of India’s largest pharmaceutical and healthcare companies, and Minrad International,

Healthcare, Mergers & Acquistions, Pharmaceuticals, Piramal Group, Piramal Healthcare Ltd

No Comments

Piramal Healthcare Limited – Conference Call to discuss Q2 FY09 results on Wednesday, 22nd October, 2008 from 5:00 PM – 6:00 PM

The Board of Directors of Piramal Healthcare Limited (PHL) will meet on Wednesday 22nd October, 2008 to consider the financial results for the quarter

Financial News, Healthcare, Pharmaceuticals, Piramal Healthcare Ltd

No Comments

Piramal Life Sciences receives DCGI Approval to conduct Phase I Trial of New Cancer Molecule P-1446A-05 in India

Piramal Life Sciences Limited, part of the Piramal Group of companies, has received regulatory approval for the initiation of a phase-I study in India

Healthcare, Pharmaceuticals, Piramal Group, Piramal Healthcare Ltd, Regulations

No Comments

Piramal Healthcare Limited Q1 FY 2009 Results

Piramal Healthcare Limited (PHL, earlier Nicholas Piramal India Limited) (NSE: PIRHEALTH, BSE: 500302) today reported first quarter (Q1) results for F

Financial News, Healthcare, Pharmaceuticals, Piramal Group, Piramal Healthcare Ltd

No Comments

Neuland Laboratories Q1 sales increases by 25.13%

• Successful execution of Contract Research as per targets set in business plans • Strategically increased market share in all major APIs manufac

Financial News, Neuland Laboratories, Pharmaceuticals

No Comments

Piramal Healthcare Acquires Haemaccel Brands Group of PlasmaSelect AG, Germany

Piramal Healthcare Limited [NSE: Pirhealth, BSE: 500302], one of India’s largest pharmaceutical and healthcare companies, and part of the Piramal Gr

Healthcare, Mergers & Acquistions, Nicholas Piramal, Pharmaceuticals, Piramal Group

No Comments